IAN LIPSKI: Open Payments
NPI 1104909001 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,029 in 73 payments from 19 companies in 2025. Trend: 2023 $3,146 · 2024 $3,013 · 2025 $2,029
Food & beverage: $2,029
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $310 |
| MML US, Inc. | 14 | $270 |
| Globus Medical, Inc. | 4 | $267 |
| Boston Scientific Corporation | 3 | $186 |
| Abbott Laboratories | 2 | $184 |
| Saluda Medical Americas, Inc. | 4 | $177 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $83 |
| PFIZER INC. | 3 | $81 |
| Nalu Medical, Inc. | 4 | $78 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
Products named: ReActiv8, Senza, PROCLAIM, Evoke, QULIPTA, WaveWriter Alpha Prime 16, BOTOX, JOURNAVX.
Industry payments across TX — which companies pay providers there.
